| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1985) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 779619577M |
| Parent Compound: | CLOBETASOL |
| InChI Key | CBGUOGMQLZIXBE-XGQKBEPLSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C25H32ClFO5 |
| Molecular Weight | 466.98 |
| AlogP | 4.1 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 80.67 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 32.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Glucocorticoid receptor agonist |
| Primary Target | |
|---|---|
| Glucocorticoid receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Pemphigoid, Bullous | 3 | D010391 | ClinicalTrials |
| Vulvar Lichen Sclerosus | 3 | D007724 | ClinicalTrials |
| Lichen Sclerosus et Atrophicus | 3 | D018459 | ClinicalTrials |
| Alopecia Areata | 3 | D000506 | ClinicalTrials |
| Dermatitis, Seborrheic | 3 | D012628 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Cataract | 3 | D002386 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
| Pulmonary Disease, Chronic Obstructive | 2 | D029424 | ClinicalTrials |
| Lichen Planus, Oral | 2 | D017676 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Lichen Planus | 2 | D008010 | ClinicalTrials |
| Dermatitis, Atopic | 1 | D003876 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 25122-46-7 |
| ChEBI | 31414 |
| ChEMBL | CHEMBL1159650 |
| DrugBank | DB01013 |
| DrugCentral | 4452 |
| EPA CompTox | DTXSID6045907 |
| FDA SRS | 779619577M |
| Guide to Pharmacology | 7062 |
| PDB | XRD |
| PharmGKB | PA164744375 |
| PubChem | 32798 |
| SureChEMBL | SCHEMBL3997 |
| ZINC | ZINC000003977767 |